AGL 38.54 Increased By ▲ 0.97 (2.58%)
AIRLINK 129.50 Decreased By ▼ -3.00 (-2.26%)
BOP 5.61 Decreased By ▼ -0.03 (-0.53%)
CNERGY 3.86 Increased By ▲ 0.09 (2.39%)
DCL 8.73 Decreased By ▼ -0.14 (-1.58%)
DFML 41.76 Increased By ▲ 0.76 (1.85%)
DGKC 88.30 Decreased By ▼ -1.86 (-2.06%)
FCCL 35.00 Decreased By ▼ -0.08 (-0.23%)
FFBL 67.35 Increased By ▲ 0.85 (1.28%)
FFL 10.61 Increased By ▲ 0.46 (4.53%)
HUBC 108.76 Increased By ▲ 2.36 (2.22%)
HUMNL 14.66 Increased By ▲ 1.26 (9.4%)
KEL 4.75 Decreased By ▼ -0.11 (-2.26%)
KOSM 6.95 Increased By ▲ 0.10 (1.46%)
MLCF 41.65 Decreased By ▼ -0.15 (-0.36%)
NBP 59.60 Increased By ▲ 1.02 (1.74%)
OGDC 183.00 Increased By ▲ 1.75 (0.97%)
PAEL 26.25 Increased By ▲ 0.55 (2.14%)
PIBTL 5.97 Increased By ▲ 0.14 (2.4%)
PPL 146.70 Decreased By ▼ -1.70 (-1.15%)
PRL 23.61 Increased By ▲ 0.39 (1.68%)
PTC 16.56 Increased By ▲ 1.32 (8.66%)
SEARL 68.30 Decreased By ▼ -0.49 (-0.71%)
TELE 7.23 Decreased By ▼ -0.01 (-0.14%)
TOMCL 35.95 Decreased By ▼ -0.05 (-0.14%)
TPLP 7.85 Increased By ▲ 0.45 (6.08%)
TREET 14.20 Decreased By ▼ -0.04 (-0.28%)
TRG 50.45 Decreased By ▼ -0.40 (-0.79%)
UNITY 26.75 Increased By ▲ 0.35 (1.33%)
WTL 1.21 No Change ▼ 0.00 (0%)
BR100 9,806 Increased By 37.8 (0.39%)
BR30 29,678 Increased By 278.1 (0.95%)
KSE100 92,304 Increased By 366.3 (0.4%)
KSE30 28,840 Increased By 96.6 (0.34%)
World

Russia aims to boost Sputnik vaccine production abroad

  • Sputnik V has been approved in more than 15 countries, including several ex-Soviet republics but also Argentina, Tunisia and Pakistan.
Published February 3, 2021

MOSCOW: Russia is working to increase production of its Sputnik V coronavirus vaccine in foreign countries, the Kremlin said Wednesday, as many European nations struggle to roll out their jabs.

"In the very near future there are plans to establish production in foreign countries, which will satisfy the demand from more and more countries," Kremlin spokesman Dmitry Peskov told reporters.

The comments come a day after The Lancet medical journal published results showing Sputnik V -- named after the Soviet-era satellite -- to be safe and 91.6 percent effective, allaying concerns over transparency.

Russia registered the vaccine in August months ahead of Western competitors but before large-scale clinical trials, leaving many experts wary.

Its developers later said the vaccine is over 90 percent effective and Russia began inoculating its citizens with the jab in December.

Sputnik V has been approved in more than 15 countries, including several ex-Soviet republics but also Argentina, Tunisia and Pakistan.

The Russian Direct Investment Fund (RDIF), which helped finance Sputnik V, has said that more than 2 million people have been inoculated with the jab around the world.

RDIF applied for registration of Sputnik V in the European Union last month and German Chancellor Angela Merkel has expressed openness to its use once the jab receives the regulatory nod.

Comments

Comments are closed.